Jane Street’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $381K | Sell |
225,164
-287,973
| -56% | -$593K | ﹤0.01% | 8670 |
|
|
2025
Q4 | $1.02M | Buy |
513,137
+317,566
| +162% | +$1.02M | ﹤0.01% | 6082 |
|
|
2025
Q3 | $569K | Sell |
195,571
-143,029
| -42% | -$329K | ﹤0.01% | 7579 |
|
|
2025
Q2 | $613K | Buy |
338,600
+61,765
| +22% | +$110K | ﹤0.01% | 6551 |
|
|
2025
Q1 | $415K | Sell |
276,835
-123,404
| -31% | -$311K | ﹤0.01% | 7209 |
|
|
2024
Q4 | $945K | Buy |
400,239
+323,306
| +420% | +$5.68M | ﹤0.01% | 5503 |
|
|
2024
Q3 | $2.26M | Sell |
76,933
-43,215
| -36% | -$995K | ﹤0.01% | 4217 |
|
|
2024
Q2 | $1.48M | Buy |
120,148
+23,761
| +25% | +$501K | ﹤0.01% | 5032 |
|
|
2024
Q1 | $1.96M | Sell |
96,387
-277,819
| -74% | -$6.4M | ﹤0.01% | 4164 |
|
|
2023
Q4 | $8.42M | Buy |
374,206
+360,686
| +2,668% | +$7.62M | ﹤0.01% | 2158 |
|
|
2023
Q3 | $225K | Sell |
13,520
-30,470
| -69% | -$604K | ﹤0.01% | 7466 |
|
|
2023
Q2 | $1.08M | Buy |
43,990
+22,434
| +104% | +$540K | ﹤0.01% | 5081 |
|
|
2023
Q1 | $520K | Buy |
21,556
+12,722
| +144% | +$352K | ﹤0.01% | 6252 |
|
|
2022
Q4 | $261K | Sell |
8,834
-14,101
| -61% | -$507K | ﹤0.01% | 7256 |
|
|
2022
Q3 | $959K | Buy |
22,935
+7,732
| +51% | +$209K | ﹤0.01% | 5480 |
|
|
2022
Q2 | $428K | Buy |
15,203
+1,972
| +15% | +$49.8K | ﹤0.01% | 7009 |
|
|
2022
Q1 | $491K | Sell |
13,231
-95,812
| -88% | -$4.06M | ﹤0.01% | 7532 |
|
|
2021
Q4 | $4.76M | Sell |
109,043
-39,607
| -27% | -$2.08M | ﹤0.01% | 2930 |
|
|
2021
Q3 | $9.23M | Sell |
148,650
-26,181
| -15% | -$2.19M | ﹤0.01% | 1895 |
|
|
2021
Q2 | $14.9M | Buy |
174,831
+102,071
| +140% | +$5.47M | 0.01% | 1329 |
|
|
2021
Q1 | $3.27M | Buy |
72,760
+16,482
| +29% | +$648K | ﹤0.01% | 3086 |
|
|
2020
Q4 | $384K | Buy |
56,278
+42,546
| +310% | +$380K | ﹤0.01% | 6091 |
|
|
2020
Q3 | $158K | Sell |
13,732
-81,222
| -86% | -$366K | ﹤0.01% | 6568 |
|
|
2020
Q2 | $292K | Buy |
94,954
+70,970
| +296% | +$322K | ﹤0.01% | 5879 |
|
|
2020
Q1 | $99K | Buy |
23,984
+6,715
| +39% | +$44.5K | ﹤0.01% | 4938 |
|
|
2019
Q4 | $90K | Buy |
17,269
+3,279
| +23% | +$5.66K | ﹤0.01% | 4861 |
|
|
2019
Q3 | $17K | Buy |
+13,990
| New | +$18K | ﹤0.01% | 4959 |
|
|
2015
Q3 | – | Sell |
-2,982
| Closed | -$36K | – | 4077 |
|
|
2015
Q2 | $36K | Buy |
+2,982
| New | +$40.9K | ﹤0.01% | 3531 |
|
|
2014
Q3 | – | Sell |
-15,297
| Closed | -$615K | – | 2980 |
|
|
2014
Q2 | $615K | Buy |
15,297
+8,770
| +134% | +$325K | 0.01% | 1256 |
|
|
2014
Q1 | $252K | Buy |
+6,527
| New | +$230K | ﹤0.01% | 2141 |
|
|
2013
Q3 | – | Sell |
-4,394
| Closed | -$68K | – | 3056 |
|
|
2013
Q2 | $68K | Buy |
+4,394
| New | +$92.9K | ﹤0.01% | 2501 |
|
Other funds holding FLNA
VCM
GC
Jane Street's FLNA Position: Q1 2026 in Review
Jane Street reduced its Filana Therapeutics (FLNA) stake by 56% in Q1 2026, selling an estimated $593K and leaving 225,164 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8670.
Jane Street first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $14.9M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Jane Street held 225,164 shares of Filana Therapeutics worth $381K as of Q1 2026.
- Jane Street sold 287,973 Filana Therapeutics shares in Q1 2026, an estimated $593K.
- Filana Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8670 holding.
- Jane Street first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
- Jane Street's Filana Therapeutics position peaked at $14.9M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.